October 27, 2009 — Women with low- to intermediate-grade ductal carcinoma in situ (DCIS) with margins 3 mm or wider had an "acceptably low rate" of ipsilateral breast events 5 years after excision ...
Ductal carcinoma in situ (DCIS) is a non-invasive breast condition found in nearly 20% of breast cancer diagnoses, but a growing number of doctors and medical experts are questioning whether the term ...
AI can use preoperative mammograms to predict postoperative breast cancer recurrence, a 2026 retrospective study has found.
If you’re diagnosed with cancer, asking which stage is likely one of your first questions. Stage 1 is the earliest, most treatable stage of cancer, while stage 4 is the most advanced and difficult to ...
Mar. 24 -- TUESDAY, Feb. 12 (HealthDay News) -- Many women diagnosed with a precancerous breast lesion known as ductal carcinoma in situ (DCIS) are highly anxious about their prognosis, even though ...
SAN ANTONIO ― Oncologists can now offer postmenopausal women with ductal carcinoma in situ (DCIS) two options for prevention of breast cancer recurrence: anastrozole (Arimidex, AstraZeneca ...
In this study, researchers aimed to examine trends in nonsurgical management and other treatment modalities in low-risk, ...
Please provide your email address to receive an email when new articles are posted on . Women with DCIS who did not identify as white had greater reductions in mental health 2 years after treatment ...